Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Rapid and demonstrable inactivation of SARS-CoV-2 is crucial to ensure operator safety during high-throughput testing of clinical samples. The inactivation efficacy of SARS-CoV-2 was evaluated using commercially available lysis buffers from three viral RNA extraction kits used on two high-throughput...

Descripción completa

Detalles Bibliográficos
Autores principales: Thom, Ruth E., Eastaugh, Lin S., O’Brien, Lyn M., Ulaeto, David O., Findlay, James S., Smither, Sophie J., Phelps, Amanda L., Stapleton, Helen L., Hamblin, Karleigh A., Weller, Simon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481894/
https://www.ncbi.nlm.nih.gov/pubmed/34604108
http://dx.doi.org/10.3389/fcimb.2021.716436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481894/
https://www.ncbi.nlm.nih.gov/pubmed/34604108
http://dx.doi.org/10.3389/fcimb.2021.716436

Ejemplares similares